Latest News & Updates
Other trending news you may like to read
Allergan Aesthetics Launches Skin Quality Index To Standardise Aesthetic Terminology, New SQI Framework Aims To Bridge Patient-Provider Communication Gap
Allergan Aesthetics, part of AbbVie, launches the Skin Quality Index framework to standardise aesthetic terminology and improve communication between patients and clinicians.
Vaibhavi M.
FDA Accepts Cogent Biosciences’ NDA For Bezuclastinib In Non-Advanced Systemic Mastocytosis With PDUFA Date Set For December 2026
U.S. Food and Drug Administration accepts Cogent Biosciences NDA for bezuclastinib in non-advanced systemic mastocytosis, setting a PDUFA decision date of December 2026.
Simantini Singh Deo
Spyre Therapeutics Completes Recruitment For RA Sub-Study Of SKYWAY Trial Ahead Of Schedule
Spyre Therapeutics completes early recruitment for RA sub-study of SKYWAY Phase 2 trial evaluating SPY072, with topline proof-of-concept data expected in Q3 2026.
Simantini Singh Deo
Recludix Pharma Expands Executive Team To Drive Growth, Innovation, And Scientific Advancements
Recludix Pharma promotes Ajay Nirula to president and Catherine Bovenizer to CFO to support pipeline growth in inflammatory disease therapies.
Simantini Singh Deo
